Prospective,Multicenter Study of Randomized Comparison of the Biolimus A9-eluting Stent With the Zotarolimus-eluting Stent in Multi-vessel PCI
Latest Information Update: 11 Jan 2022
At a glance
- Drugs Umirolimus (Primary) ; Zotarolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms BATTLE-IN-MULTI
- 31 Aug 2021 Status changed from active, no longer recruiting to completed.
- 17 Feb 2021 Planned End Date changed from 1 Dec 2020 to 1 Jun 2021.
- 17 Feb 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Jun 2021.